Results 211 to 220 of about 45,078 (268)
Safety and immunogenicity of PanChol, a single-dose live-attenuated oral cholera vaccine: results from a phase 1a, double-blind, randomized, placebo-controlled trial
Leitner DR, Walsh SR, Suzuki M, Desjardins M, Hannaford A, Sherman AC, Levine H, Carr L, Hammerness E, Osaki A, Sullivan E, Wang B, Balazs GI, Park Chang JB, Slater DM, Puri N, Kuehl CJ, Chen WH, Harris JB, Piantadosi S, Baden LR, Waldor MK. +21 moreeuropepmc +1 more sourceInfluence of PPV, PRV and PRRSV on Efficacy of the Lapinized Hog Cholera Vaccine and Pathogenicity of Classical swine fever virus
, 2012 Ning Yi-bao, Yun Zhao, Qin Wang, Xuezheng Fan, Yuming Qin, Guangchuan Zhang, Lu Xu, Hui-shen QIU, Wang Zai-shi, Song Li, Qingchun Shen, Qizu Zhao +11 moreopenalex +1 more sourceEffectiveness of a single dose of oral cholera vaccine: findings from epidemiological and genomic surveillance ofVibrio Choleraein the Democratic Republic of the Congo (PICHA7 Program)
George CM, Namunesha A, Endres K, Felicien W, Sanvura P, Bisimwa J, Perin J, Bengehya J, Maheshe G, Cikomola C, Bisimwa L, Mwishingo A, Sack DA, Domman D. +13 moreeuropepmc +1 more sourceSafety and immunogenicity of the Euvichol-S oral cholera vaccine for prevention of Vibrio cholerae O1 infection in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial.
Lancet Glob HealthSong KR, Chapagain RH, Tamrakar D, Shrestha R, Kanodia P, Chaudhary S, Wartel TA, Yang JS, Kim DR, Lee J, Park EL, Cho H, Lee J, Thaisrivichai P, Vemula S, Kim BM, Gupta B, Saluja T, Pansuriya RK, Ganapathy R, Baik YO, Lee YJ, Jeon S, Park Y, Her HL, Park Y, Lynch JA. +26 moreeuropepmc +1 more source
